responses by a P AF antagonist. The effects evoked by endothelins on phosphoinositide metabolism and P AF production were, to a certain extent, dependent on the presence of extracellular Ca 2 +. In addition, ET induced changes in Ca 2 + dynamics, evoking an initial and rapid intracellular mobilization and influx of Ca 2 + and, later, a maintained Cal + influx. These findings contribute to the understanding of the pathophysiological role of ET in the blood-brain barrier (BBB) . Key Words: Endothelin Brain microvessels-Phosphoinositides-Platelet activat ing factor-Cal", On the other hand. endothelial cells from rat brain microvessels express receptor sites for ET. Some of these (receptor sites) are coupled to phospholipase C. Thus. it has been reported that ET-1 stimulates DNA synthesis involving phosphat idyl inositol hy drolysis (Vigne et aI., 1990) and increases intracellu lar calcium mobilization in brain capillary endothe lial cells (Vigne et aI., 1990 (Vigne et aI., , 1991 . In addition, en dothelins inhibit cholera toxin-stimulated adenylate cyclase and increase phospholipase C activity (La doux and Frelin, 1991; Stanimirovic et aI., 1993; Purkiss et aI., 1994) . Although important in formation may be obtained from analysis of cell cul tures, study of intact microvessels can provide use ful information to clarify the complexity that exists in vivo in the blood-brain barrier (BBB). In fact, accumulating evidence suggests that the endothelial cells forming the cerebral microvasculature consist of a heterogeneous, rather than homogeneous, cell popUlation, and cultured cell properties may be al tered during long-term culture (Kobayashi et aI., 1994; Tontsch and Bauer, 1991) . Therefore, studies performed on microvessels are important to the un derstanding of how endothelins are able to regulate the BBB. In this regard, Dallaire et al. (1992) re ported that endothelins alter phosphate uptake by isolated capillaries. However, the mechanism by which such actions are evoked is not known.
On the other hand, platelet-activating factor (PAF) is a mediator generated from membrane phospholipids with potent platelet activity and che motactic properties (Braquet et aI., 1987) . PAF pro duction has been demonstrated in endothelial cells (Camussi et aI., 1990; Stewart et aI., 1990; Whatley et aI., 1990 Whatley et aI., , 1992 Clay et aI., 1991) . Recent evi dence suggests that PAF may mediate certain ac tions of ET -1. Indeed, PAF receptor antagonists are reported to attenuate the bronchoconstrictor action of ET-l (Filep, 1992) , inhibit ET-l -induced increase in intracellular calcium levels (Takayasu et aI., 1989) , protect against ET-l -induced sudden death in mice and rats (Terashita et aI., 1989) , and reduce some vascular responses of ET -1 (Takayasu Okishio et aI., 1990; Filep et aI., 1991; Kurose et aI., 1991) . Furthermore, ET-l has been shown to stim ulate PAF synthesis in mesangial cells (Lopez Farre et aI., 1991; Montero et aI., 1993) .
Taking into account all of these considerations, this study was performed on intact cerebral mi crovessels mainly to examine the action of the en dothelins on phosphoinositide metabolism. In addi tion, the possibility that PAF release arises by ET action was also examined.
METHODS

Chemicals
Carrier-free e 2 P]orthophosphate, [3H]myo-inositol (specific activity of 14. 3 Ci/mmol), [3H]sodium acetate (specific activity 3. 6 Cilmmol), and 4 5CaCl 2 (specific ac tivity 13.4 mCi/mg) were purchased from Amersham In ternational. Endothelins and quinacrine were from Sigma Chemical Co, (St Louis, MO, U. S. A.). Fura-2 AM was from Molecular Probes Inc. (Eugene, OR, U. S.A.). High performance thin layer chromatography plates were pur chased from Merck (Darmstad, Germany). Diacylglyc erol (DAG) assay system was obtained from Amersham. All other reagents were of the highest analytical grade available.
Isolation of brain microvessels
Cerebral microvessels were isolated basically as de scribed previously (Catalan et aI. , 1989b) . Brains were removed from male Wi star rats by decapitation and placed in a cold medium (buffer A) containing 15 mM HEPES (pH 7. 4), 103 mM NaCI, 4. 7 mM KCI, I. 2 mM KH 2 P0 4 , 1.2 mM MgS0 4 , 25 mM NaHC0 3 , and 10 mM glucose. Brainstem, cerebellum, and meninges were care fully removed and discarded, and the cerebral cortical grey matter was homogenized using a hand-driven pestle (20 strokes at 400 rpm) in 5 vol of buffer A. After centrif ugation at 1,000 x g for 10 min at 4°C, the pellet was resuspended in 4 vol of buffer A containing 15% dextran and centrifuged at 5,000 x g for 10 min at 4°C to remove J Cereb Blood Flow Metab, Vol. 16, No.6, 1996 the myelin. The resulting pellet, consisting mainly of mi crovessels and erythrocytes, was resuspended in buffer A and poured onto a nylon sieve, pore-size 150 fJ.. m. The filtrate was subsequently passed over a column (2.5 x 8 cm) of 0.45 mm diameter glass beads. Microvessels re tained on the glass beads were separated by decantation and centrifugation at 5,000 x g for 10 min at 4°C. Finally, the pellet was resuspended at a final concentration of 0. 1-0. 5 mg protein/ml in buffer A supplemented with 1 mg/ml bovine serum albumin, 1 mM CaCI 2 , I mM inosi tol, and I mM cytidine (buffer B). Before assays, mi crovessels were preincubated for 15 min at 37°C under an atmosphere of 95% O 2 and 5% CO 2 (vol/vol). The purity of the preparation was quite satisfactory from both mor phological and biochemical criteria, and neuronal con taminants were negligible.
Assays of phosphoinositide turnover
To analyze the effect of endothelins on 3 2 p incorpora tion into phospholipids, microvessels were prelabeled in a phosphate-free medium in the presence of 100 fJ.. Ci/ml r3 2 p]orthophosphate for 30 min. Thereafter, ET treatment was carried out for the appropriate times. In some exper iments, the effects of endothelins in the presence or ab sence of 250 fJ.. M quinacrine or 5 mM EGT A were also analyzed. Incubations were stopped by removing the me dium and replacing it with cold chloroform/methanol/13 N HCI (20: 100:0.75, vol/vol/vol) as described previously (Catalan et aI. , 1991) . Then, phospholipids were extracted according to Jolles et a!. (1979) . Phospholipid separation was performed by thin layer chromatography (TLC) using silica gel high performance TLC plates impregnated with 1% potassium oxalate in methanol/water (2:3, vol/vol), and chromatograms were developed as described previ ously (Catalan et a!. , 1991) . Dried plates were autoradio graphed overnight using AGFA x-ray film. Silica gel sec tions corresponding to labeled phosphoinositides, phos phatidic acid (PA), and PAF were scraped off into vials and the radioactivity determined.
DAG content was determined essentially as described by Preiss et a!. (1986) , with a bacterial DAG kinase to convert cellular DAG to 3 2 P-Iabeled P A, using the DAG assay system (Amersham International). Samples were extracted with chloroform/methanol, and 3 2 p_PA in the chloroform extract was quantified by liquid scintillation, after separation by TLC as described above.
To analyze the production of inositol phosphates by treatment with endothelins, microvessels were incubated in an inositol-free medium at 37°C with 20 fJ.. Ci/ml eHlmyo-inositol. After 120 min, 10 mM LiCI was added and ET treatment was carried out. Incubations were stopped by addition of 1 vol of 20% cold trichloroacetic acid, and extracts were washed five times with water saturated ether and then neutralized before analysis. Ino sitol phosphates were separated by anion-exchange high performance liquid chromatography (HPLC) with Ultra sil-SAX column (4. 6 x 250 mm; Beckman) as described previously (Batty et a!., 1985) .
Measurement of calcium movement
To estimate Ca 2 + efflux, cerebral microvessels, resus pended in the buffer A described above, were equili brated with 1 mM 4 5CaCi 2 (1. 5 fJ.. Ci/ml) at 35°C for 45 min. Then, 10-7 M ET was added, and the reaction stopped at different times. Samples were filtered rapidly through Whatman GF/B filters, washed three times with a solu-tion containing 10 mM Tris HC!, pH 7, and 200 mM su crose. Radioactivity was determined by a standard liquid scintillation technique.
In order to measure intracellular Ca" + levels, mi crovessels were preincubated in buffer B for 15 min and then were loaded with 5 f.LM fura-2 AM at 37°C for 30 min under an atmosphere of 95% O 2 and 5% CO 2 (vol/vol). Microvessels were washed to release extracellular dye, and resuspended in Ca2 + -free buffer B supplied with 250 f.LM sulfinpirazone. Samples were incubated for 10 min in the presence of 0. 7 mM Ca2+ in a final volume of 0. 5 ml. Finally, microvesscls were resuspended in the same buffer B with or without Ca2 + in a cuvette with constant shaking at 37°C before addition of ET. Calcium measure ments were determined in a volume of 2. 5 ml by fluores cence using a RS 1000 Schoeffel (Schoeffel Instruments, Ltd. ) spectrophotofluorimeter. Excitation wavelength was 340 nm and emission was monitored at 505 nm. Flu orescence measurements were calculated as described previously (Grynkiewicz et aI. , 1985) after subtracting background fluorescence measured in microvessels not loaded with fura-2. Maximum bioavailability, F max' was determined after lysing microvessels with 160 f.LM digito nin in the presence of 1. 5 mM Ca2 + , and F mi n was mea sured after adding 10 mM EGT A and 20 mM Tris. pH 8.7. Higher concentrations of EGT A produced no further de crease in F m in' The apparent disassociation constant, Ku' of the fura-2/Ca2 + complex was 224 nM.
Production and biological activity of P AF After phospholipid separation described above, the spot corresponding to PAF was scraped off the plates. and extracted with chloroform/methanol/water (I :2:0. 8, vol/vol/vol) as described previously (Hanahan, 1990) . Samples were dried under nitrogen and resuspended in Tyrode-HEPES, pH 7. 4, containing 134 mM NaC!, 12 mM NaHC0 3 , 2. 9 mM KCI, 0. 34 mM NaH 2 P04• 1 mM MgC1 2 ,5 mM HEPES, 5 mM glucose, and 0.3% bovine
serum albumin. To analyze the biological activity of PAF, washed rabbit platelets, obtained as described previously (Catalan et aI., 1993a l. were treated with the PAF fraction isolated as described above. Incubations were performed as previously reported (Catalan et aI. , 1993a) . The PAF activity of the lipid extracted by this fashion was deter mined by testing both P A increase and protein phosphor ylation from washed rabbit platelets, which have been previously loaded with [32p]orthophosphate (Catalan et al. , 1989a) .
In some experiments incorporation of radioactive pre cursors into PAF and its modulation by ET was studied. For this, isolated microvessels were incubated with either 100 f.LCi/ml [32Pjorthophosphate or 200 f.LCi/ml [3Hlacetate for 30 min or 15 min respectively. Then, 10-7 M ET-l was added. After different times (from 1 min to 10 min), radioactivity incorporation into PAF was measured.
Analysis of results
Each result represents the mean of triplicate determi nation ± SD. Statistical analysis of the data was done using Student's {-test. Differences with a p-value of <0.05 were considered statistically significant.
RESULTS
Effects of ETs on phosphoinositide turnover
Treatment of brain microvessels prelabeled with e2P]orthophosphate with the three ET isoforms re sulted in an increase of phosphoinositide turnover in a dose-dependent manner, 10-7 M being the maximal effective dose used. Figure I labeling by 40% and an increase in PA labeling to nearly 190% over control value: 450 x 10�5 pmol/mg protein in PIP 2 and 23 x 1O�5 pmol/mg protein in PAl, which was obtained with 10 7M ET-1. e, ET-1; 0, ET-2; 6, ET-3. Bars represent standard deviation. n = 3. Values obtained with ET-1 and ET-2 at a concentration >1 O� 10 M were statistically significant (p < 0.05); values obtained with ET-3 at concentrations >10�9 M were statistically significant (p < 0.05). same pattern of variation by ETs (data not shown). It is noteworthy that the effect of ET-3 was smaller than that of other ET isopeptides. The EC so of both ET-I and ET-2 was 10-8 M, whereas ET-3 showed an EC50 of 5 x 10-8 M. On the other hand, 10-7 M of any ET isoform increased PA formation at I min, peaked at 5 min, and then was decreased at 15 min (Fig. 2 ). In addition, ETs caused an early decrease of 32 p incorporation into PIP z at I min, then re turned to basal through 15 min. Effects of both ET-I and ET-2 were again more pronounced than that of ET-3. These effects were, at least in part, calcium dependent. Thus, incubation of microvessels in a Ca z+ -free medium with 5 mM EGT A resulted in a reduction of the 1 min ET -I induced variations by >50%, abolishing the ET action at 5 min of treat ment (Fig. 3) . The measurement of phosphoinositide metabo lites (i.e., DAG and inositol phosphates) showed that the variations elicited by ET are the result of phospholipase C activation ( Figs. 4 and 5) . Thus, the addition of 10 -7 M ET -I to brain microvessels induced a time-dependent increase of DAG levels (Fig. 4) . Accumulation of DAG was detected as early as 30 s, and then DAG levels decreased and were maintained for at least 15 min.
The time course for accumulation of inositol phosphates in response to ET -I was also deter mined ( Fig. 5 ). Both inositol 1,4,5-trisphosphate (IP 3 ) and inositol 1,4-bisphosphate (lP z ) levels rose rapidly at 30 s. lnositol l-monophosphate OP) levels increased linearly due to the inclusion of Li + during the stimulation period, which inhibits the hydrolysis of IP z and mainly that of IP. 
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Involvement of Ca 2+ in ET effect
To test the effect of ET-l on intracellular Ca 2+ , experiments were performed using fura-2-loaded microvessels. In the presence of extracellular Ca z + , 10-7 M ET -1 induced an initial and rapid Ca 2 + peak followed by a second sustained phase (Fig. 6A) . When ET -I was added to microvessels incubated in a Ca 2 + -free medium, the transient increase was at tenuated and the sustained phase abolished (Fig.  6B) .
On the other hand, results obtained when mi crovessels were equilibrated with 4S Ca 2+ for 45 min to label the internal stores, showed that 10-7 M ET causes a rapid, but transient, increase in the Ca 2+ efflux (Fig. 6C) . Thus, after 45 s, 4S Ca Z + reached basal levels. Untreated microvessels did not show any oscillations of radioactivity.
P AF production by ET
After ET -I treatment, 3z P-prelabeled brain mi crovessels were able to produce 32 p_ P AF. Once phospholipids were fractionated, PAF was located on the TLC plate between the area corresponding to sphingomyelin (Rf value = 0.28) and lyso phos phatidylcholine (Rf value = 0.14) as described pre viously (Hanahan, 1990) . The area comigrating with authentic PAF was scraped off the plates, ex tracted, and its biological activity analyzed.
The extracted P AF was added to washed rabbit platelets, and aggregation rapidly occurred (data not shown). Furthermore, ET-induced PAF also caused P A formation and 40 kDa protein phosphor ylation (Fig. 7, panels A and B respectively) . Pre treatment of platelets with 10 fJ-M WEB 2086, a spe- cific PAF receptor antagonist, reduced all these ef fects evoked by ET -induced PAF in platelets (Fig. 7) . To test whether PAF was released to the extra cellular medium, some incubations were finished by centrifugation, and aliquots of the supernatant and resuspended sediment were measured for radioac tivity. Results showed that PAF was not released to the extracellular medium (data not shown).
Using 3 2 p as labeled precursor of PAF, incorpo ration of label into PAF after treatment with 10 -7 M ETs was studied. As can be seen in Fig. 8A , max imal incorporation was observed after 5 min of treatment with both ET-l and ET-2. After 15 min, incorporation returned to basal value. Figure 8 also shows the dose-response curves for the stimulation of PAF production. Maximal stimulation was evoked by both ET-l and ET-2 (10-7 M). In any case, no effect was observed when ET-3 was as sayed (Fig. 8B) .
Additional experiments were carried out to fur ther characterize the ET-evoked PAF production. Thus, it is noteworthy that ET-l did not stimulate 3 2 p incorporation into P AF in the presence of either 5 mM EGTA or 250 fLM quinacrine, an inhibitor of phospholipase A 2 ( Fig. 9 ).
DISCUSSION
Several important points emerge from the present data. Most of all, ETs are effective in inducing phosphoinositide hydrolysis and subsequent resyn thesis in intact cerebral microvessels. This hydro lysis is mediated by phospholipase C activation, as shown by the rapid production of inositol phos phates together with an increase of DAG mass and PA labeling. However, we must take into consider ation that other phospholipases (i.e., phospholipase D) and/or other phospholipids (i.e., phosphatidyl choline) might be involved in overall PA production as well as DAG generation.
There is previous evidence that many ET re sponses are mediated by phospholipase C activa- All values were statistically significant (p < 0.05). tion in other tissues and cells (see review by Ya nagisawa and Masaki, 1989b). However, there ap pear to be substantial differences in the mechanism of action of ET among different species and cells. Therefore, the study and the elucidation in the BBB of the signal transduction pathways involved in ET actions are relevant in determining the significance of this peptide in the BBB. Intact cerebral mi crovessels constitute a tissue for which no previous studies on ET signal transduction have been re ported. Studies done in isolated capillary endothe lial cells (Vigne et a!., 1990 (Vigne et a!., , 1991 Ladoux and Fre lin, 1991; Stanimirovic et aI., 1993 Stanimirovic et aI., , 1994 Purkiss et aI., 1994) show that both phospholipases C and A2 are involved. Since cerebral endothelial cells rap idly lose their characteristics of differentiated bar rier in culture (Kobayashi et aI., 1994; Tontsch and Bauer, 1991; Risau and Walburg, 1990) , intact ce- rebral microvessels appear to be a better model for the study of BBB functionality than are cultured endothelial cells. In fact, there are controversial data about the ability of these cells in culture to secrete ET (Yoshimoto et aI., 1990; Vigne et aI., 1990) and about the kinetic characteristics of inosi tol phosphate production by stimulation with the peptide (Vigne et aI., 1990; Ladoux et aI., 1991; Stanimirovic et al., 1993 Stanimirovic et al., , 1994 Purkiss et aI., 1994) . Furthermore, it has been described that cultured endothelial cells could be a kind of injured cell since they produce more ET than does the microvessel itself (Yoshimoto et aI., 1990) . It is noteworthy that the potency of both ET-l and ET-2 to stimulate phospholipase C in intact mi crovessels was higher than that of ET-3, in accor dance with data reported for cerebrovascular endo thelial cells (Stanimirovic et aI., 1993 (Stanimirovic et aI., , 1994 Purkiss A, B) . Cerebral microvessels were loaded with fura-2 AM for 30 min. After washing, they were resuspended in a medium with 1 mM CaCI 2 (panel A) or without CaCI 2 (panel B). Then, treatment with 10 7M ET-1 was carried out for the times indicated. Intracellular Ca 2 + concentration was monitored as described under Methods. Results are from a representative experiment, which was repeated for three times with similar results. Time-course of ET-1-stimulated 45Ca 2 + efflux (C). After prelabeling with 1 mM 45Ca 2 t (1.5 J.1Cilml) for 45 min, 10 -7 M ET-1 was added. Incubations were stopped and radioactivity remaining in the microvessels was estimated. Values represent percent age variations with respect to control values (45Ca 2 ; labeling of microvessels without any addition after 45 min prelabeling). e ET-1; 0, control. Bars represent standard deviation. n = 3. In C, the value obtained before 45 s was statistically significant (p < 0.05). , 1994) . Actually, ET receptors in endothelial cells from brain microvessels are coupled to phos pholipase C, but recognize ET-3 with low affinity, in contrast to the selectivity shown for ET-1 (Vigne et a\., 1991) . This fact could indicate that they are of the ETA type, since ET B receptors show equipotent affinity for all three ETs, according to the classifi cation of ET receptors (Sakurai et aI., 1992) . In agreement with this fact, the ETA receptor antago nist BQ 123 has been shown to inhibit the IP 3 for mation elicited by ET in endothelial cells from hu man microvessels (Stanimirovic et aI., 1994) . Besides stimulating phosphoinositide turnover, both ET-1 and ET-2, but not ET-3, treatments evoked the appearance of 32 p radioactivity in a chromatographic band when phospholipids were fractionated. Identification of this band by standard and biological probes demonstrated that it was a PAF-like material. Evocation of aggregation, pro duction of PA, and increase of endogenous protein phosphorylation in platelets, together with the re versal of these responses by a PAF antagonist, were used as biological probes. The finding that ET evokes PAF synthesis agrees with previous obser vations (Lopez-Farre et aI., 1991; Montero et aI., 1993) and also confirms other studies suggesting that PAF mediates certain actions of ET (Filep et aI., 1991; Filep, 1992; Kurose et aI., 1991; Takayasu et aI., 1989; Takayasu-Okishio et aI., 1990; Tera shita et a\., 1989) .
To our knowledge, this is the first report of PAF production by cerebral microvessels. Our present results show that the characteristics of PAF produc tion by cerebral microvessels are similar to those of PAF release by endothelial cells from other vessels. PAF is generated in these cells after agonist activa tion and requires the presence of extracellular cat ions and the activation of phospholipase A 2 , indi cating that the remodeling pathway of PAF biosyn thesis is involved (Camussi et aI., 1986; Whatley et a\., 1990) . In addition, none of the endothelial PAF is released into the extracellular medium (Stewart et a\., 1990) , a fact that has led to the proposal that PAF is expressed in the outer leaflet of the endo thelial cell membrane, causing contacting neutro phils to adhere. In contrast, the PAF produced by mammalian central nervous system neurons is de tected in the cells and in the extracellular medium. In addition, its production is practically indepen dent of calcium, a fact that could suggest that the de novo biosynthesis pathway is the main route for PAF production (Yue et a\., 1990) . Therefore, from the data reported here, it is quite logical to assume that P AF from cerebral microvessels is mainly, if not exclusively, produced by endothelial cells.
We have previously reported that in cerebral mi crovessels, translocation of protein kinase C is evoked by PAF (Catalan et aI., 1993b) . Therefore, we suggest that PAF might have a second messen ger role in ET action on cerebral microvessels, as has been suggested in other biological systems (Stewart et aI., 1990) .
Previous studies, performed with different cell types, suggest that the effects of ET are generally mediated by inositol phospholipid turnover, and re quire extracellular Ca 2+ (Yanagisawa and Masaki, 1989b; Highsmith et aI., 1992) . Results of our ex periments performed with cerebral microvessels in Ca 2+ -free media, showing that ET actions are im paired in these conditions, agree with results from other tissues. However, the earliest ET-induced (1 min) phosphoinositide turnover is only partially Ca 2 + -dependent in contrast to the fully Ca 2 + - dependent responses observed when the time of ET treatment was �5 min (i.e., phosphoinositide turn over and PAF production). With respect to ET induced changes in Ca 2 + dynamics in cerebral mi crovessels, the ability of the peptide to induce an initial Ca 2+ spike, followed by a prolonged plateau, suggests the involvement of different Ca 2 + signal ing pathways. Results indicated that the observed initial spike is likely to be due to both an IPrevoked mobilization of intracellular Ca 2 + and a Ca 2 + in flux. On the other hand, since the plateau is abol ished by extracellular Ca 2+ depletion, we suggest that this is due to a Ca 2 + influx. Similar Ca 2 + move ments induced by ET have been previously re ported in other biological systems (see review by Highsmith et aI., 1992) . The Ca 2+ influx might be due to channels gated by IP3/inositol tetrakisphosphate; channels gated by other second messengers, such as DAG (Berridge and Irvine, 1989) ; or to voltage-dependent chan nels. Previous data on the type of Ca 2+ membrane channels involved in ET action have demonstrated that both voltage-sensitive and insensitive channels are implicated in a cell-specific fashion (see review by Highsmith et al., 1992) . In endothelium from ce rebral microvessels, partial involvement of voltage dependent Ca 2+ channels in ET-induced IP3 forma tion, arachidonate release, and the increased per meability has been reported (Stanimirovic et aI., 1993) . In addition, we have observed that ET evokes a rapid Ca 2+ efflux in cerebral microves sels. In agreement with this phenomenon, we must J Cereb Blood Flow Me/ab, Vol. 16, No. 6, 1996 point out that the peptide has been shown to evoke Ca 2+ efflux in vascular smooth muscle due to mo bilization of intracellular Ca 2+ stores (Bialecki et aI., 1989) , Involvement of ETs in the pathogenesis of vas cular disorders, such as stroke, hypertension, and subarachnoid hemorrhage (Sakurai and Goto, Fig.  1 . Then, microvessels were treated for 2 min with 5 mM EGTA or for 10 min with 250 fl.M quinacrine. Then, 10 -7 M ET-1 was added and, after 5 min, PAF was extracted and analyzed as in Methods. Results are expressed as percentage of control value (100). Bars represent standard deviation. n = 3. Values for ET-1 were statistically significant (p < 0.05). 1993), and in the function of the BBB (Vigne et a\., 199 1) has been reported. Therefore, a precise knowledge of the molecular mechanism of ET ac tion on BBB microvessels is a requisite to the de velopment of an effective therapy. As an example, from the evidence reported here, the therapeutic use of both PAF and Ca 2 + antagonists in BBB dis eases in which ETs are involved has the potential for effectiveness.
